Ukwelashwa kwe-CAR-T kwe-Acute Myeloid Leukemia (AML)

I-Acute Myeloid Leukemia (AML) umdlavuza okhula ngokushesha wegazi kanye nomnkantsha wamathambo, obonakala ngokukhula okungalawuleki kwamangqamuzana amhlophe egazi angakavuthwa. I-AML inolaka futhi ivame ukuba nzima ukuyelapha, ikakhulukazi lapho iziguli ziphindela emuva noma zingabe zisakwazi ukwelapha ngendlela ejwayelekile njengokwelashwa ngamakhemikhali noma ukufakelwa amaseli e-stem. Ukwelashwa kwe-CAR-T (Chimeric Antigen Receptor T-cell) kuyindlela entsha, esezingeni eliphezulu eletha ithemba ezigulini ezine-AML ephindela emuva noma engaphenduli, enikeza ikhambi elenzelwe umuntu siqu neliqondiwe lapho ukwelashwa kwendabuko kwehluleka.

Ukwelashwa kwe-CAR-T kuhilela ubunjiniyela bamaseli e-T esiguli ukuze abone futhi ahlasele kangcono amaseli omdlavuza. Ku-AML, amaseli e-CAR-T aklanyelwe ukuhlasela ama-antigen athile avela ebusweni bamaseli ane-leukemic, avame ukutholakala kumaseli e-AML. Ngokuhlela kabusha amaseli e-T esiguli ukuze abone futhi abhubhise la maseli anonya, ukwelashwa kwe-CAR-T kunikeza ithuba lokuphulukiswa okuphelele kanye nokusinda isikhathi eside, ngisho nasezigulini ezinezinketho zokwelapha ezilinganiselwe.

• Ukusebenza Okuphezulu kwe-AML Ebuyela Emuva Ne-RefractoryUkwelashwa kwe-CAR-T kubonise ithemba elikhulu ezigulini ezine-AML ebuye noma ezingasabeli ekwelashweni kwendabuko.
• Ukwelashwa Okuqondiwe: Ngokuqondisa ngqo amangqamuzana e-leukemia, ukwelashwa kwe-CAR-T kunciphisa umonakalo kumaseli anempilo, okunikeza ukwelashwa okunembe kakhulu uma kuqhathaniswa nokwelashwa okuvamile.
• Kwenziwe Ngokwezifiso Futhi Kunobusha: Ukwelashwa kwe-CAR-T kuklanyelwe isiguli ngasinye, kusetshenziswa amaseli abo e-T ohlelweni lokwelashwa oluqondene kakhulu, okuholela ekwehleni kwengozi yokwenqatshwa.
• Kungenzeka Ukuthethelelwa Kwesikhathi EsideIziguli eziningi ziye zathola ukuphumula okuhlala isikhathi eside kanye nokuqothulwa ngokuphelele kwamaseli e-leukemic ngemuva kokwelashwa nge-CAR-T.

• Iqoqo lamaseli e-TIsinyathelo sokuqala sihilela ukuqoqa amaseli e-T egazini lesiguli ngenqubo ebizwa ngokuthi i-leukapheresis.
• Ubunjiniyela bamaseli e-TAmaseli e-T aqoqiwe abe eseguqulwa elabhorethri ukuze aveze i-receptor ehlose ama-antigen athile e-AML afana I-CD33 noma CD123.
• Ukufakwa kwamaseli e-T aguquliwe: Ngemva kokwandisa ama-T-cell aklanywe ngendlela ehlukile, aphinde afakwe egazini lesiguli.
• Ukuqapha Nokululama Ngemva Kokwelashwa: Ngemva kokufakwa, iziguli ziqashwe ngokucophelela ukuze zithole imiphumela emibi, njenge-cytokine release syndrome (CRS) noma ubuthi be-neurotoxicity, okuvame ukuphathwa ngokungenelela kwezokwelapha ngesikhathi esifanele.

• Ubuchwepheshe be-CAR-T obusezingeni eliphezuluI-BIOOCUS isebenzisa intuthuko yakamuva kubuchwepheshe be-CAR-T ukunikeza iziguli izinketho zokwelapha ezisebenza kahle kakhulu nezisezingeni eliphezulu ze-AML.
• Ithimba Lokunakekelwa KochwephesheIthimba lethu lochwepheshe be-hematology kanye nochwepheshe be-immunotherapy basebenzisana ukuhlinzeka ngokunakekelwa komuntu siqu kwesiguli ngasinye, ukuqinisekisa imiphumela emihle kakhulu.
• Impumelelo Efakazelwe Ekwelashweni Kwe-AML: Siye senza ngempumelelo iziguli eziningi ezine-AML ephinde yabuya noma engaphili kahle sisebenzisa ukwelashwa kwe-CAR-T, sathola ukuthuthuka okukhulu kanye nokukhululeka.
• Ukusekelwa Okuphelele Kweziguli Zamazwe Ngamazwe: I-BIOOCUS inikeza ukwesekwa okuphelele ezigulini zamazwe ngamazwe, okuhlanganisa ukubonisana, ukwelashwa, kanye nokunakekelwa kwangemva kokwelashwa, okuqinisekisa uhambo olubushelelezi kuyo yonke inqubo.

• Ukwelashwa kwe-CAR-T kwe-AML kubonise impumelelo enkulu ekwelapheni amacala aphinde abuyele esimweni sawo kanye nalawo angalapheki, kanti iziguli eziningi zithola ukuthuthuka okukhulu kwezokwelapha. Izifundo ezilandelayo zibonisa amandla okuguqula ukwelashwa kwe-CAR-T ekwelapheni i-AML:

  • Indaba Yesiguli: Owasinda ku-AML, Iminyaka Engu-9 Ngemva Kokufakelwa—Ukwamukela Amandla Ethemba Nokuzalwa Kabusha
  • Intsha Ibuyisa Ithemba Ngemva Kokuxilongwa Nge-AML—Uhambo Lokuqina Nokululama
  • Ukunqoba I-Acute Myeloid Leukemia Nokuzalwa Kabusha Ngemva Kokufakelwa Iseli Le-Stem

  Lezi zindaba zangempela zibonisa amandla okwelashwa kwe-CAR-T okuthuthukisa kakhulu imiphumela yeziguli futhi zinikeze ithemba elisha kulabo ababhekene ne-AML. Iziguli zibonise izimpendulo ezimangalisayo, okuhlanganisa ukuphulukiswa kwesikhathi eside kanye nokululama, ngisho nangemva kokwehluleka ukwelashwa kwangaphambilini.